Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nea 14 Gp, Ltd
Relationship:   10% Owner
City:   Timonium
State:   MD
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   92,551,179    

Indirect Shares

   9,425,523      
Direct Value   $90,342,523    

Indirect Value

   $18,405,859      
Total Shares   101,976,702      
Total Value   $108,748,383      


Loxo Oncology, Inc. $0 Avalo Therapeutics, Inc $255,585 Adaptimmune Therapeutics PLC $89,202,068 Tracon Pharmaceuticals, Inc. $884,871 Enliven Therapeutics Ord Shs $0 Loxo Oncology, Inc. $0 Avalo Therapeutics, Inc $255,585 Adaptimmune Therapeutics PLC $89,202,068 Tracon Pharmaceuticals, Inc. $884,871 Enliven Therapeutics Ord Shs $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Loxo Oncology, Inc. LOXO 10% Owner 2013-08-06 1,789,420 2013-08-06 0    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 594,245 2015-10-20 0    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 2018-09-07 82,978,668 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2018-03-27 3,466,003 2018-03-27 3,466,003    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2020-09-14 0 2020-09-14 5,959,520    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 0 2018-02-13 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 2018-05-01 0 2018-05-01 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN 10% Owner 2021-12-23 3,722,843 2021-12-09 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-23 4 S $2.41 $57,746 D/D (23,961) 3,722,843 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-22 4 S $2.32 $46,679 D/D (20,109) 3,746,804 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-21 4 S $2.32 $95,804 D/D (41,222) 3,766,913 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-20 4 S $2.21 $192,604 D/D (85,123) 3,808,135 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-16 4 S $2.23 $100,546 D/D (44,993) 3,893,258 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-15 4 S $2.28 $65,685 D/D (28,817) 3,938,251 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-14 4 S $2.56 $38,643 D/D (15,093) 3,967,068 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-13 4 S $2.83 $49,558 D/D (17,501) 3,982,161 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-10 4 S $2.83 $24,541 D/D (8,667) 3,999,662 0 -
ELVN Enliven Therapeutics Ord ... 10% Owner   –       –       •   2021-12-09 4 S $2.95 $16,693 D/D (5,666) 4,008,329 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-09-14 4 D $0.00 $0 D/D (20,000) 0 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-09-14 4 D $0.00 $0 I/I (2,000,000) 5,959,520 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-09-14 4 A $0.00 $0 D/D 20,000 20,000 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-04-09 4 D $0.00 $0 D/D (40,000) 0 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-04-09 4 A $0.00 $0 D/D 40,000 40,000 0 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2020-04-09 4 D $0.00 $0 I/I (4,000,000) 7,959,520 0 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-09-07 4 B $1.67 $5,000,100 D/D 3,000,000 82,978,668 2.45 -
MULE Mulesoft, Inc 10% Owner   –       –       •   2018-05-01 4 A $0.00 $0 D/D 12,679,970 12,679,970 0 -
MULE Mulesoft, Inc 10% Owner   –       –       •   2018-05-01 4 D $0.00 $0 D/D (12,679,970) 0 0 -
TCON Tracon Pharmaceuticals, I... 10% Owner   –       –       •   2018-03-27 4 B $2.70 $1,911,503 I/I 707,964 3,466,003 1.5 -
TCON Tracon Pharmaceuticals, I... 10% Owner   –       –       •   2018-03-27 4 B $2.70 $1,911,503 D/D 707,964 3,466,003 2.45 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-27 4 B $1.92 $11,500,200 D/D 6,000,000 79,978,672 2.45 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-26 4 B $1.90 $1,087,553 D/D 571,164 73,978,672 2.45 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-23 4 B $1.95 $572,358 D/D 294,090 73,407,508 2.45 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-22 4 B $1.90 $1,655,669 D/D 869,574 73,113,418 2.45 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us